Z
Zonsen Pelib Biotech
Peptide Information Compression Technology (PICT)
About Zonsen Pelib Biotech
Peplib.com is at the forefront of peptide drug discovery, offering unique peptide library products and high-throughput screening services. The company has developed a groundbreaking peptide library containing sequence information of billions of peptides, each separately isolated. This includes all possible pentapeptides and hexapeptides, enabling unprecedented high-throughput screening at the biomolecule, cell, and even live animal levels. Peplib.com serves pharmaceutical companies, biotech firms, and academic research institutions, operating in the global biotechnology and pharmaceutical markets. The business model is based on providing specialized peptide libraries and screening services, generating revenue through service contracts and product sales.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jul 2025 | $14M | $151M | ShengNuo Biology · Xiangjiang State Investment · CDH Investments | ↗ |
| SERIES A✓Equity / VC | Apr 2021 | $30M | $121M | Highlight Capital · CAS Investment Management · Cowin Capital · ASBV | — |
Growth signals
Latest recorded traffic for Zonsen Pelib Biotech is 90 monthly website visits, up 200% over the last three months. Zonsen Pelib Biotech's team grew 60% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Zonsen Pelib Biotech in its local ecosystem
The Zonsen Pelib Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
Highlight Capital
CAS Investment Management
Cowin Capital- ASASBV
Legend Star- FCFortune Capital
CDH Investments- SBShengNuo Biology
- XIXiangjiang State Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zonsen Pelib Biotech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zonsen Pelib Biotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






